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Plasmonics-active gold nanoparticles offer excellent potential in molecular imaging and
cancer therapy. Among them, gold nanostars (AuNS) exhibit cross-platform flexibility as
multimodal contrast agents for macroscopic X-ray computer tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography (PET), as well as nanoprobes for
photoacoustic tomography (PAT), two-photon photoluminescence (TPL), and surface-
enhanced Raman spectroscopy (SERS). Their surfactant-free surface enables versatile
functionalization to enhance cancer targeting, and allow triggered drug release. AuNS
can also be used as an efficient platform for drug carrying, photothermal therapy, and
photodynamic therapy (PDT). This review paper presents the latest progress regarding
AuNS as a promising nanoplatform for cancer nanotheranostics. Future research
directions with AuNS for biomedical applications will also be discussed.
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Introduction
Nanotheranostics, combining diagnostic and therapeutic functions into one nanoparticle, has
attracted great attention due to its promise as a powerful tool for personalized therapy to treat
cancer, which contributes to more than seven million deaths each year (Ferlay et al., 2010; Jemal
et al., 2010; Wang et al., 2014). Theranostic nanoprobes can potentially be used for image-guided
cancer therapy with improved targeting specificity and therapeutic efficacy (Choi et al., 2012).
Nanoparticles of sizes ranging from 20 to 100 nm accumulate in tumors through the well-known
enhanced permeability and retention (EPR) effect that originates from the leaky tumor vasculature
(Maeda, 2001;Maeda et al., 2001, 2003; Sykes et al., 2014). Furthermore, targeting ligands, including
antibodies and peptides, can be functionalized on nanoparticles for active cancer targeting (Kim
et al., 2011b). Various nanoplatforms, including liposomes, iron oxide nanoparticles, and gold
nanoparticles have been developed for cancer imaging and treatment (Ahmad et al., 2010; Xie et al.,
2010; Lee et al., 2014; Wang et al., 2014). In particular, gold nanoparticles have demonstrated great
biocompatibility, plasmonic properties, and convenience in versatile functionalization through
strong gold-thiol interactions (30–40 kcal/mol), as can be exemplified by gold nanorods, nanoshells,
and nanocages in preclinical and clinical cancermanagement (Ramachandran et al., 2003; Loo et al.,
2004; Alekseeva et al., 2006; Choi et al., 2012; Huschka et al., 2012; Xia et al., 2012b; Ahmadi and
Arami, 2014; Lee et al., 2014; Xia and Xia, 2014). Those established plasmonic gold nanoplatforms
(nanorods, nanoshells and nanocages) have been widely used in previous studies for in vitro and
in vivo investigations of cancer imaging with positron emission tomography (PET), magnetic
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resonance imaging (MRI), X-ray computer tomography (CT),
high resolution optical imaging with labeled fluorescence dyes as
well as photothermal therapy (PTT) and photodynamic therapy
(PDT). Furthermore, gold nanospheres and nanoshells have been
used in clinical trials for drug delivery and photothermal therapy,
respectively (Gad et al., 2012). Therefore, novel nanoplatforms
are of great interest for cancer detection and treatment.
Gold nanostars (AuNS), with multiple sharp branches
(Figure 1A), have superior tip-enhanced plasmonic properties
in the near-infrared (NIR) tissue optical window, which is
suitable for in vivo biomedical applications. Plasmonic AuNS
have been applied for in vivo lymphatic system mapping with
photoacoustic tomography (PAT) (Kim et al., 2011a). AuNS with
silica shells have been found to be internalized into living cells
and can be used for intracellular imaging (Rodriguez-Lorenzo
et al., 2011; Fales et al., 2013; Yuan et al., 2013a). In addition,
AuNS surface-enhanced Raman scattering (SERS) nanoprobes
have been applied for immuno-SERS microscopy of the tumor
suppressor p63, imaged in prostate biopsies (Schutz et al., 2011).
SERS takes advantage of a unique phenomenon on certain
metal nanoparticles, surface plasmon resonance (SPR). Surface
plasmon refers to oscillating electrons within the conduction
band when the metallic nanostructure surface is excited by
an external electromagnetic field. The oscillating electrons can
generate a secondary electromagnetic field, which is added to the
external electromagnetic field to result in SPR. Incident photon
energy, when in resonance with the surface plasmon, magnifies
the local electromagnetic field that dramatically enhances the
intrinsically weak Raman signal. The SERS enhancement factor
is typically 106–108-fold and can be up to 1015-fold in hot
spots, where the electromagnetic field is extremely intense
(Liu et al., 2015b). By combining resonance enhancement,
surface-enhanced resonance Raman scattering (SERRS) shows
even greater Raman signal enhancement than SERS alone.
Silica-coated AuNS SERRS nanoprobes have been used for
visualizing brain tumormargins andmicroscopic tumor invasion
(Harmsen et al., 2015). Our group has developed a novel toxic
surfactant-free AuNS synthesis method that greatly improves the
biocompatibility and the versatility of surface functionalization
(Yuan et al., 2012b). In this review paper, we will focus on the
latest progress achieved in our laboratory related to AuNS and
discuss their bright future for theranostic applications.
Multimodal Imaging
AuNS provide a powerful tool for 3D in vivo tracking and
disease detection with whole body scans. For CT imaging,
gold nanoparticles are superior to traditional iodinated contrast
agents, since gold has a higher atomic number (Z = 79) and k-
edge value (80.7 keV). In addition, the X-ray attenuation of iodine
is decreased by water while that of gold is not. Gold nanoparticles
can absorb X-ray, which subsequently generate photoelectric and
Compton effects. These effects lead to formation of secondary
electrons and reactive oxygen species (ROS), the yield of which
correlates with the surface area of nanoparticles (Misawa and
Takahashi, 2011). Since star-shaped geometry exhibits greater
surface area than the spherical counterpart of equivalent size,
AuNS can be an improved sensitizer for radiation therapy. For
MRI imaging, Gd3+ ions have been linked to the AuNS surface
through 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
(DOTA) chelator. As shown in Figure 1B, tumor cells loaded
with multifunctional AuNS probes display high intensity under
CT and MRI examination (Liu et al., 2013a). PET scan provides
an extremely sensitive 3D imaging method. The sensitivity could
reach picomolar for PET compared to micromolar for MRI. We
performed PET imaging with 64Cu-labeled AuNS nanoprobes
for dynamic imaging up to 24 h (Figure 1D). In vivo tracking
results showed that the developed AuNS nanoprobes accumulate
gradually in tumor with 3.3:1 tumor-to-muscle ratio at the end of
24 h (Liu et al., 2015b). These studies exemplify the potential of
AuNS for whole body imaging.
In addition, AuNS have been exploited as a powerful
optical contrast agent under multiphoton microscope for high-
resolution imaging. With an exceptionally high two-photon
photoluminescence (TPL) [more than one million Göeppert-
Mayer (GM) two-photon action cross-section (TPACS)], AuNS
offer superior signal contrast than quantum dots or other
organic fluorophores for multiphoton optical imaging (Yuan
et al., 2012b). Furthermore, a recent study investigated TPL of
single gold nanoparticle with different shapes and the TPACS
were reported to be 83,500, 1.5 × 103, 4.2 × 104, 4.0 ×
106 GM for nanosphere, nanocube, nanotriangle, nanorod and
nanostar, respectively (Gao et al., 2014). The TPACS of AuNS
is almost two orders higher than that of gold nanorod, which
is the highest one among other shapes. With an intense TPL
emission, AuNS can be used not only for real-time in vivo
tracking, but also for sensitive tumor detection following
systemic injection of AuNS (Yuan et al., 2012c). As shown
from TPL imaging in Figure 1C, transactivator of transcription
(TAT)-functionalized AuNS nanoprobes have much stronger
signal in cells than that of AuNS without TAT functionalization.
TAT is a well-known cell-penetrating peptide with capability to
increase nanoparticle cellular uptake. Although the TPL imaging
depth is limited by the extent of laser penetration, optical
microscopy offers the highest spatial resolution among most
animal imaging modalities. AuNS are also suitable to be used
under PAT with high extinction coefficient (∼1010 M−1cm−1)
(Xia et al., 2012a; Yuan et al., 2014). Being a potent contrast
agent for PAT, which is an optical-ultrasound hybrid imaging
technology, the particokinetics and biodistribution of the AuNS
can be studied with deeper imaging depth and larger field of
view.
Furthermore, AuNS have been applied for SERS detection
with tip-enhanced plasmonics. The reported SERS enhancement
factor is several orders higher than that of gold nanospheres
(Yuan et al., 2013a). SERS applies nanometallic structures to
enhance “fingerprint” Raman spectra, which provides a method
for molecular sensing with high sensitivity (Liu and Sun, 2011;
Liu et al., 2013b,c; Yuan et al., 2013b; Zhao et al., 2014a).
Our group demonstrated the first analytical application of
SERS in chemical analysis using nanostructured metal substrates
30 years ago, and has been working on various types of
SERS nanoplatforms, including nanogratings, nanorod arrays,
nanowires and AuNS, for biochemical sensing (Meier et al., 1985;
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FIGURE 1 | (A) TEM images of synthesized AuNS (left), silica-coated AuNS
(middle), and silver coated-AuNS (right). (B) CT (left) and MRI (right) imaging
with developed multifunctional AuNS nanoprobe. (C) Demonstration of
TAT-peptide enhanced TPL imaging, photodynamic therapy (PDT), and
surface-enhanced Raman scattering (SERS) imaging after 1-h incubation
with the AuNS probe. Scale bars for TPL, PDT and SERS image are 10, 250,
and 20µm, respectively. (D) PET/CT imaging with 64Cu labeled AuNS
probe, which was injected intravenously through tail vein. Dynamic imaging
at various time pointes were acquired. Arrow shows tumor (Fales et al.,
2011, 2013, 2014; Yuan et al., 2013a; Liu et al., 2015b).
Enlow et al., 1986; Alak and Vo-Dinh, 1987; Bello et al., 1989; Vo-
Dinh et al., 1994, 2013; Stokes et al., 2004; Yuan et al., 2013a).
SERRS AuNS nanoprobes have been developed to perform
quantitative ex vivo multiplex detection with high sensitivity
(Yuan et al., 2013b). The AuNS nanoprobes have also been used
for SERS imaging for cancer cells as shown in Figure 1C (Fales
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et al., 2013). SERS images were acquired at 633 nm with a 2-µm
step size by using a Renishaw Raman microscope. The 633 nm
resonant dye, DTDC was used to label the AuNS for SERS
detection. SERS imaging shows that TAT-functionalized AuNS
nanoprobes have much stronger signal inside cells. Recently, we
have reported the synthesis of silver-coated AuNS (AuNS@Ag)
that provide over an order of magnitude increase in SERS
signal when compared to AuNS alone (Fales et al., 2014). We
have applied the AuNS@Ag for in vitro homogenous nucleic
acid detection, which demonstrated AuNS’ strong capability for
molecular sensing with the SERS method (Wang et al., 2015).
With such flexibility, AuNS thus are a promising nanoplatform
for multimodality imaging from whole body scan to high-
resolution optical imaging as well as molecular sensing.
Brain Tumor Imaging
The potential of AuNS as an efficient contrast agent has further
been investigated in animal brain tumor models (Yuan et al.,
2014). Through cranial window chambers implanted with tumor
cells in live animals, AuNS have been employed for angiography
with high spatial resolution; cerebral capillaries were clearly
visible with minimal tissue autofluorescence background. Unlike
conventional contrast agents (e.g., FITC-dextran) showing signal
decay within 30min, AuNS can be coated with polyethylene
glycol (PEG) to achieve a much longer intravascular signal
stability due to its extended serum half-life (several hours) and
lower degree of extravasation.
The main challenge of tumor imaging is delivering the
contrast sufficiently to the target. Several physiological barriers
exist between the injection site and the target tumor cells.
For example, nanoparticles need to survive immunoclearance,
extravasate tumor vessels, permeate the blood brain barrier
(BBB), diffuse through interstitium, and penetrate the plasma
membrane into cells (Chrastina et al., 2011; Goldberg et al.,
2013). For brain tumor imaging, the greatest challenge lies in the
permeation of the BBB. Tight junctions between the endothelial
cells and podocytes from the astrocytes form a highly selective
barrier that prevents large molecules from passing through.
To date, the typical 24-h post-injection brain accumulation of
nanoparticles may still be less than 0.1% of the initial dosage
(Khlebtsov and Dykman, 2011); this is similar to those obtained
after monoclonal antibody infusion. Several nanoparticle-based
platforms have been studied, including transferrin-containing
gold nanoparticles (Wiley et al., 2013), polysorbate 80-coated
poly(n-butyl cyanoacrylate) dextran polymers (Koffie et al.,
2011), and angiopep2 peptide-functionalized dendrimers (Yan
et al., 2012). Since AuNS are a strong contrast agent, it is therefore
prudent to investigate the effect of surface functionalization on
brain tumor targeting.
Nanoparticles accumulate in tumors typically through passive
and active mechanisms. While surface PEGylation achieves the
former, the latter requires surface functionalization of peptides or
proteins. Upon systemic exposure, PEGylated AuNS accumulate
passively near the tumor periphery and around blood vessels.
Hyper-neovascularity along the tumor edge and interstitial fluid
pressure gradient at the boundary attenuate the penetration
of AuNS deep into the tumor. PEG-AuNS also accumulate in
vascular endothelial cells but with minimal true transcytosis(Ye
et al., 2013), where paracellular extravasation is most likely
attributed to the defective tight junction at the tumor site.
With extravasation depending on the nanoparticle size and
incubation time (Yuan et al., 1994; Popovic et al., 2010), smaller
nanoparticles or longer incubation may further increase the
tumor accumulation or extravasation depth.
Comparing the brain tumor AuNS delivery through passive
and active mechanisms, we coated 80-nm AuNS with PEG
(PEG-AuNS) and TAT peptides (TAT-AuNS), and 50-nm AuNS
with angiopep2 peptides (angiopep2-AuNS). Angiopep2-peptide
has recently been exploited to deliver nano-drugs into the
brain via lipoprotein receptor related protein (Gabathuler,
2010). PEG-AuNS accumulated in the tumor periphery and
parenchyma but much less in the normal brain. They also
accumulated inside endothelial cells and perivascular spaces,
particularly in the tumor regions of defective vascular integrity.
As shown in Figure 2, TAT-AuNS accumulated less in tumor but
extensively in liver compared to PEG-AuNS. Positively charged
TAT possibly attracted opsonins, causing greater entrapment in
the reticuloendothelial system. In contrast, smaller angiopep2-
AuNS had a deeper distribution inside tumor parenchyma
with relatively less liver accumulation. Calculated from the
AuNS intensity ratio from the images collected under the same
microscopic settings, the average tumor/liver AuNS density
ratios are 0.32, 0.03 and 1.2 for PEG-, TAT- and angiopep2-
coated AuNS. These findings suggest that enhanced tumor BBB
permeation with selected intratumoral delivery can be achieved
with proper control of AuNS sizes and selection of surface ligand
chemistry.
AuNS for Phototherapy
AuNS have also been applied for PDT and photothermal therapy
(PTT). PDT uses a photosensitizer that generates ROS upon
irradiation to kill cells, while photothermal therapy transduces
light to heat for cancer hyperthermia or ablation. The effect of
laser type on PTT has been investigated before and the results
showed that pulsed lasers could use 10 times less energy to kill
cancer cells than that used for continuous-wavelength (CW)
lasers (Huang and El-Sayed, 2011). That is because pulsed-laser
with gold nanoparticles can lead to a variety of therapeutic
effects including protein denaturation, cell cavitation, bubble
formation from shock waves and plasma generation (Pustovalov
et al., 2008). With the nanoparticle’s tumor targeting effect and
focused irradiation to the tumor site, phototherapy can achieve
greater tumor therapeutic specificity with less off-target effects.
The therapeutic potentials have been demonstrated on gold
nanoshells, nanocages, and nanorods (Von Maltzahn et al., 2009;
Xie et al., 2010; Day et al., 2011). Gold nanoshells were used to
perform PTT (800-nm diode laser, 4 W/cm2 intensity for 3min.)
with murine xenograft models and results showed significant
survival rate improvement for the treatment group with 57%
of mice remaining tumor free at the end of 90 days, while
the mean survival date for the control group was only 13.3
days. Gold nanocages functionalized with HER2-antibody have
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FIGURE 2 | TPL images of DAPI- (nucleus; blue) and CD31 (blood
vessel; red)-stained cryosectioned specimens from perfused brain
excised 48-hr after injection (5 pmole; 80 nm) of neutral PEG-AuNS
(A–C) and positively-charged TAT-AuNS (D–F), and injection (1 pmole;
50nm) of angiopep2-AuNS (G–I). Large-area tile images showing
distribution of PEG-AuNS (A), TAT-AuNS (D), Angiopep2-AuNS (G)
preferentially in the brain tumor than normal brain. T, tumor. N, normal.
Charged TAT-AuNS accumulated greater in the liver hence lower intratumoral
accumulation. Smaller angiopep2-AuNS was more widespread in the tumor.
Scale bar: 100µm (Yuan et al., 2014).
been used to perform PTT with a femtosecond Ti:Sapphire laser
(810 nm, 1.5 W/cm2 for 5min) for SK-BR-3 breast cancer cells.
The treatment group shows a majority of cells died while there
was little cellular death in the control group (Skrabalak et al.,
2007). Gold nanorods with T790 dye embedded in a silica shell
were developed to perform PDT and the improved treatment
efficiency has been demonstrated with HepG2 cancer cells (Zhao
et al., 2014b). In particular, the star-shape geometry of AuNS
generates a strong tip-enhanced plasmonic effect that greatly
increases the photothermal transduction efficiency especially
in the NIR tissue optical window. Successful photothermolysis
has been demonstrated in both single photon and two photon
settings (Yuan et al., 2012a,c). An ultralow irradiance of 0.2
W/cm2 (at using 850 nm pulsed laser), which was below the
maximal permissible exposure of skin, was reported. A recent
study demonstrated that AuNS exhibit higher photothermal
transduction efficiency than gold nanoshells (90–94% for AuNS
compared to 61% for gold nanoshells). In vivo experiment
also revealed a successful photothermal ablation of aggressive
sarcoma tumor in mouse after AuNS systemical injection
through tail vein (Liu et al., 2015a). In addition, we also
loaded Protoporphyrin IX onto silica-coated AuNS for PDT
showing specific cytotoxic effect only on the UV exposed region
(Figure 1C) (Fales et al., 2013). These results demonstrated that
AuNS have great potential for PDT and photothermal therapy in
future preclinical cancer treatment studies.
Conclusion and Future Perspective
The AuNS synthesized with the surfactant-free method
provide a novel nanoplatform for cancer nanotheranostics.
The multifunctional AuNS nanoprobes can be used for future
pre-treatment cancer diagnostics with PET, MRI, and CT
scan, intraoperative imaging with TPL, PAT, and SERS, and
image-guided therapy with PDT and PTT. The plasmonic
AuNS is a promising theranostic nanoplatform since they
have combined capabilities for diagnostics with various
imaging modalities from whole-body to subcellular level,
therapeutics with phototherapy and drug delivery, and surface
functionalization versatility for cancer targeting. Compared to
other gold plasmonic nanoplatforms, the AuNS nanoprobes
have unique advantages of tip-enhanced plasmonics, high
TPL cross-section, and excellent photon-to-heat conversion
efficiency, toxic surfactant-free synthesis. Further studies on
relationship between AuNS properties including particle size
and surface charge, and their biodistribution are still required
to improve nanoprobe uptake in tumor for better biomedical
applications. With promising findings from previous studies,
AuNS demonstrate great potential for translational medicine
studies as a combined nanoplatform for both cancer imaging and
therapy.
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